Seer (SEER) Depreciation and Depletion (2020 - 2026)
Seer (SEER) posted quarterly Depreciation and Depletion of $1.5 million for Q1 2026, down 6.25% year-over-year from $1.6 million in Q1 2025, and little changed quarter-over-quarter from $1.5 million in Q4 2025.
Seer (SEER) Depreciation and Depletion (2020 - 2026) Analysis & Trends
Seer's Depreciation and Depletion history runs 7 years deep, the most recent figure standing at $1.5 million for Q1 2026.
- In Q1 2026, Depreciation and Depletion fell 6.25% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $6.0 million (down 4.76% YoY), while the FY2025 annual figure was $6.1 million, down 1.61% from the prior year.
- Depreciation and Depletion for Q1 2026 stood at $1.5 million, roughly flat from $1.5 million in the prior quarter.
- The five-year high for Depreciation and Depletion was $1.6 million in Q4 2023, with the low at $900000.0 in Q1 2022.
- The 5-year median for Depreciation and Depletion is $1.5 million (2024), against an average of $1.4 million.
- The sharpest annual moves came in 2022 and 2025: Depreciation and Depletion surged 80.0% in 2022, then fell 6.25% in 2025.
- Seer's Depreciation and Depletion stood at $1.1 million in 2022, then jumped by 45.45% to $1.6 million in 2023, then changed by 0.0% to $1.6 million in 2024, then dropped by 6.25% to $1.5 million in 2025, then changed by 0.0% to $1.5 million in 2026.
- Business Quant data shows SEER's Depreciation and Depletion at $1.5 million in Q1 2026, $1.5 million in Q4 2025, and $1.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.10 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 38.91 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 3.18 Mn |
| 10 | Seer | 230.63 Mn | 230.63 Mn | 1.51 Mn | 1.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.50 Mn |
| Jun 30, 2026 | 1.50 Mn |
| Mar 31, 2026 | 1.50 Mn |
| Mar 31, 2026 | 1.50 Mn |
| Dec 31, 2025 | 1.50 Mn |
| Dec 31, 2025 | 1.50 Mn |
| Sep 30, 2025 | 1.50 Mn |
| Sep 30, 2025 | 1.50 Mn |
| Jun 30, 2025 | 1.50 Mn |
| Jun 30, 2025 | 1.50 Mn |
| Mar 31, 2025 | 1.60 Mn |
| Mar 31, 2025 | 1.60 Mn |
| Dec 31, 2024 | 1.60 Mn |
| Dec 31, 2024 | 1.60 Mn |
| Sep 30, 2024 | 1.60 Mn |
| Sep 30, 2024 | 1.60 Mn |
| Jun 30, 2024 | 1.50 Mn |
| Jun 30, 2024 | 1.50 Mn |
| Mar 31, 2024 | 1.50 Mn |
| Mar 31, 2024 | 1.50 Mn |